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1  | INTRODUC TION
Fungal infections today are among the most difficult diseases to 
manage in humans (Kohler et al., 2014). Fungi collectively kill over 
1.5 million people annually which is more than malaria and similar 
to the death toll from tuberculosis (Brown et al., 2012; Bongomin 
et al., 2017). Increasing resistance to the limited arsenal of antifun-
gal drugs is a serious concern, especially for Candida and Aspergillus 
infections, for which the therapeutic options are limited. Overall, 
there is an urgent need to develop new antifungal strategies to 
tackle fungal infections (Denning and Bromley, 2015; Nicola et al., 
2019).
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Abstract
Fungal diseases are responsible for the deaths of over 1.5 million people worldwide 
annually. Antifungal peptides represent a useful source of antifungals with novel 
mechanisms-of-action, and potentially provide new methods of overcoming resist-
ance. Here we investigate the mode-of-action of the small, rationally designed syn-
thetic antifungal peptide PAF26 using the model fungus Neurospora crassa. Here we 
show that the cell killing activity of PAF26 is dependent on extracellular Ca2+ and 
the presence of fully functioning fungal Ca2+ homeostatic/signaling machinery. In 
a screen of mutants with deletions in Ca2+-signaling machinery, we identified three 
mutants more tolerant to PAF26. The Ca2+ ATPase NCA-2 was found to be involved 
in the initial interaction of PAF26 with the cell envelope. The vacuolar Ca2+ channel 
YVC-1 was shown to be essential for its accumulation and concentration within the 
vacuolar system. The Ca2+ channel CCH-1 was found to be required to prevent the 
translocation of PAF26 across the plasma membrane. In the wild type, Ca2+ removal 
from the medium resulted in the peptide remaining trapped in small vesicles as in 
the Δyvc-1 mutant. It is, therefore, apparent that cell killing by PAF26 is complex and 
unusually dependent on extracellular Ca2+ and components of the Ca2+-regulatory 
machinery.
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Antifungal peptides (AFPs) and peptide-related molecules are 
being intensively studied as alternatives for the therapeutic control 
of pathogenic fungi (Matejuk et al., 2010; Duncan and O'Neil, 2013; 
Rautenbach et al., 2016; Nicola et al., 2019). A detailed understand-
ing of their antimicrobial mechanisms is of high priority if peptides 
are to be considered as useful antifungal agents. These studies may 
also aid the identification of novel targets for antifungal therapy 
(Muñoz et al., 2013a; Rautenbach et al., 2016). Furthermore, this 
mechanistic understanding is guiding the de novo design and mod-
ification of natural peptides in order to circumvent their limitations 
(e.g., instability, toxicity, interactions with other drugs, poor kinetics, 
resistance mechanisms, etc) and thus improve their antimicrobial ef-
ficacy (Nicola et al., 2019). Overall, AFPs offer promising alternatives 
to standard therapies as anti-infectives and immunomodulatory 
agents with mechanisms-of-action less prone to resistance induction 
compared to conventional antibiotics (Mahlapuu et al., 2016).
PAF26 is a synthetic hexapeptide that has been shown to be 
highly effective at killing filamentous fungi while showing low tox-
icity against human and bacterial cells (Munoz et al., 2006). Unlike 
membrane permeabilizing antimicrobials, initial investigations into 
the mode-of-action of PAF26 indicated that it did not directly per-
meabilize the plasma membrane. Instead, at low fungicidal concen-
trations, PAF26 has a dynamic antifungal mechanism-of-action that 
involves at least three stages: peptide interaction with the fungal 
cell envelope (cell wall and/or plasma membrane), endocytic inter-
nalization and accumulation in the vacuole followed by vacuolar 
expansion. At a certain point, PAF26 is actively transported out of 
the vacuole into the cytoplasm, followed by a series of complex and 
specific intracellular effects whose relationship with the eventual 
death of the target fungus is still unclear (Muñoz et al., 2012). Two 
functional and separate motifs (cationic and hydrophobic domains) 
in the peptide amino acid sequence have been identified as playing 
important roles in the antimicrobial mode-of-action (Muñoz et al., 
2013). As a result of these studies, PAF26 has been proposed as a 
simple peptide model for the characterization and study of cationic, 
cell-penetrating AFPs (Muñoz et al., 2012; 2013a).
From average measurements of fungal cell populations ex-
pressing the genetically encoded Ca2+-reporter aequorin, cytosolic 
free Ca2+ concentrations ([Ca2+]cyt) within Neurospora crassa spore 
germlings treated with a low inhibitory concentration of PAF26 
(2.5-5 µM) have been shown to exhibit a biphasic increase in re-
sponse to PAF26, and this biphasic [Ca2+]cyt increase is completely 
dependent on the PAF26 and extracellular Ca2+ concentrations. 
The second phase of the biphasic [Ca2+]cyt increase was found to 
be energy dependent because it was blocked by treatment with the 
metabolic inhibitor, sodium azide (NaN3). This may link PAF26 inter-
nalization with actin-dependent endocytosis. Consistent with endo-
cytic internalization playing a key role in PAF26 internalization, is 
the inhibition by the F-actin inhibitor, Latrucunulin A and a reduced 
uptake rate in endocytosis by the endocytic mutants Δrvs-167, Δrvs-
161, and Δrab-5 (Muñoz et al., 2012; 2013a). At high fungicidal con-
centrations (15 µM), PAF26 killed cells even after NaN3 treatment, 
although in a different manner. Under these conditions, the peptide 
first bound to the cell envelope as before, but was then observed to 
directly enter the cytoplasm, indicating passive transport across the 
plasma membrane at high concentrations (Muñoz et al., 2012).
In the current research, evidence for Ca2+-signaling having a sig-
nificant role in the PAF26 mode-of-action was analyzed by testing 
and analyzing the PAF26 sensitivity of deletion mutants defective in 
different components of their Ca2+-signaling machinery. The pattern 
and kinetics of peptide interaction, internalization and distribution 
within the cells of PAF26-resistant mutants were compared with the 
parental wild type using fluorescently labeled PAF26 combined with 
live-cell imaging. The role of external Ca2+ in these processes and 
vacuolar fusion was assessed.
2  | RESULTS
2.1 | Sensitivity of fungal cells to killing by PAF26 is 
dependent on extracellular Ca2+
To confirm that extracellular Ca2+ plays a role in determining the 
sensitivity of N. crassa to PAF26 (Muñoz et al., 2012), and thus Ca2+ 
homeostasis being involved in the mode-of-action of PAF26; the 
wild-type strain was grown in: (a) standard Vögels medium (VM) 
(0.64 mM Ca2+); (b) Ca2+ free VM (in which Ca2+ had been omitted); 
and (c) VM with twice the normal concentration of Ca2+ (1.28 mM). 
The IC50 values for the wild type under these different media are 
shown in Figure 1a. The IC50 in standard VM was 3.7 ± 0.6 µM and 
in VM lacking Ca2+ was 6.4 ± 0.9 µM, a significant increase in re-
sistance against PAF26 (p ≤ .001). VM with 2 X Ca2+ had an IC50 
value of 2.5 ± 0.4 µM, a significant increase in sensitivity to PAF26 
(p ≤ .01) compared with standard VM. These results are consistent 
with a Ca2+-dependent mechanism playing a role in determining the 
sensitivity of N. crassa to PAF26 involving uptake of Ca2+ from the 
external medium.
2.2 | PAF26 requires a functional [Ca2+]cyt 
homeostatic machinery in order to kill fungal cells
To assess whether Ca2+-homeostasis and signaling play a role in the 
mode-of-action of PAF26; 24 homokaryotic deletion mutants of 
genes encoding proteins predicted to be components of the N. crassa 
Ca2+-homeostatic machinery were screened for increased PAF26 
tolerance/ sensitivity. The predicted locations of these proteins in 
the fungal cell are shown in Figure 1c; The results of the screen are 
in Table 1.
The first group of mutants screened were defective in the follow-
ing Ca2+-channel proteins: CCH-1 and MID-1, which are components 
of the high affinity Ca2+-influx system (HACS); FIG-1, which forms 
the low-affinity Ca2+-influx system (LACS); and, the vacuolar Ca2+ 
channel, YVC-1. Two of these mutants (∆cch-1 and ∆yvc-1) exhib-
ited significantly increased tolerance against PAF26 (p ≤ .001) when 
compared with the wild type (Figure 1b). The IC50 values of ∆cch-1 
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and ∆yvc-1 were both above the level (~10 µM) at which PAF26 di-
rectly permeabilizes the plasma membrane of N. crassa wild-type 
cells (Muñoz et al., 2012).
N. crassa has eight Ca2+ ATPases (Zelter et al., 2004), for which 
seven deletion mutants were available as homokaryons for screen-
ing: Δnca-1, Δnca-2, Δnca-3, Δpmr-1, Δph-7, Δcta-3, and Δcta-4. 
Δnca-2, Δcta-3, and Δcta-4 exhibited significantly increased toler-
ance against PAF26 (p ≤ .001) when compared with the wild type 
(Figure 1b); with Δnca-2 approaching inhibitory levels of PAF26 that 
directly permeabilize the membrane in the wild type.
Homokaryotic deletion mutants of six of the eight predicted N. 
crassa antiporters involved in Ca2+ transport (Zelter et al., 2004) 
were available for screening: Δcax, Δtrm-14, Δtrm-15, Δtrm-16, 
Δtrm-18, and Δtrm-20 (Figure 1b, Table 1). Δtrm-20 showed signifi-
cantly greater tolerance (p ≤ .01) to PAF26 compared with the wild 
type although this was less than a twofold increase (Figure 1b).
F I G U R E  1   Ca2+ plays a significant role in the mode-of-action of PAF26. (A) shows the effects of both the removal and increase of free 
Ca2+ in the media on the IC50 of PAF26 by fungal cells. Increasing the level lowers the concentration at which PAF26 is effective and removing 
Ca2+ increases the concentration. Both of these results are significant; One-way ANOVA with Dunnet's comparison test: F(2,12) = 58.85, p = 
≤.001, R2 = 90.75, R2(adj) = 89.21. The Low Ca2+ VM (M = 6.410 ± 0.941) was significantly different from the Normal VM (M = 3.868 ± 0.288) 
at p = ≤.001 and the 2X Ca2+ (M = 2.342 ± 0.331) was significantly different from Normal VM at p = ≤.01 (B) shows the effects of deleting 
components of the Ca2+ homeostasis machinery on susceptibility to PAF26. 6 were significantly more tolerant than the wild type; One-
way ANOVA with Dunnet's comparison test: F(17,106) = 60.13, p = ≤.001, R2 = 90.61, R2(adj) = 89.10. Δcch-1 (M = 15.595 ± 2.649), Δyvc-1 
(M = 11.375 ± 1.419), Δnca-2 (M = 8.442 ± 0.838), Δcta-3 (M = 9.099 ± 1.677) and Δcta-4 (M = 8.212 ± 0.594) were significantly more tolerant 
than the wild type (M = 3.756 ± 0.193) at p = ≤.001, and Δtrm-20 (M = 6.637 ± 1.234) was significant at p = ≤.01. Each assay consisted of 
eight technical and three biological replicates, figures are representative. The predicted localizations of these is shown in (C) based on the 
localization of their protein orthologs in S. cerevisiae yeast cells and vegetative hyphae of N. crassa (Wada et al., 1987; Yang and Sachs, 1989; 
Bertl and Slayman, 1990; Diamond et al., 1991; Antebi and Fink, 1992; Iida et al., 1994; Lapinskas et al., 1995; Levina et al., 1995; Paidhungat 
and Garrett, 1997; Erdman et al., 1998; Kanzaki, 1999; Benito et al., 2000; Locke et al., 2000; Muller et al., 2001; Palmer et al., 2001; 
Courchesne, 2002; Courchesne and Ozturk, 2002; Denis and Cyert, 2002; Gupta et al., 2003; Kaiserer et al., 2003; Muller et al., 2003; Zhou 
et al., 2003; Zelter et al., 2004; Brand et al., 2007; Hallen and Trail, 2008; Lew et al., 2008; Benito et al., 2009; Bormann and Tudzynski, 2009; 
Bowman et al., 2009; 2011; Binder et al., 2010; Cavinder et al., 2011) [Colour figure can be viewed at wileyonlinelibrary.com]
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2.3 | PAF26 is taken up by wild-type macroconidia 
into vacuoles which fuse and then lyse before 
releasing the peptide into the cytoplasm
In order to compare the dynamic pattern of peptide-cell interactions 
between the wild type and the mutants, PAF26 labeled with the fluo-
rophore TAMRA (TMR-PAF26) was imaged. Fluorescent labeling has 
been previously employed to monitor, using confocal live-cell imag-
ing, the dynamic localization of PAF26 or related peptides in a range 
of fungi. We are confident that the dynamic pattern of TMR-PAF26 
staining provides a faithful localization of the unlabeled peptide in 
fungal cells and labeled/unlabeled peptides have similar IC50 values 
(Muñoz et al., 2012; 2013a; 2013b). Previously it has been shown 
that wild-type macroconidia treated with a low fungicidal concen-
tration of FITC-PAF26 (2.5 µM) exhibit a similar time-dependent 
staining pattern as germlings treated with the same concentration 
of PAF26 (Muñoz et al., 2012). A similar localization pattern of TMR-
PAF26 interaction, internalization and distribution was observed 
with ungerminated macroconidia to that of FITC-PAF26. The use of 
macroconidia allowed a basic monitoring of cell volume, surface area 
and developmental state in relation to possible variations in morpho-
genesis and staining patterns.
2.4 | The dynamic pattern of TMR-PAF26 in Ca2+ 
homeostasis mutant staining provides insights 
into the localization and roles of the defective 
mutant proteins
In order to gain more insight into which stages of the PAF26 in-
teraction, uptake and distribution process the CCH-1, YVC-1, and 
NCA-2 proteins influence, the time-dependent staining by TMR-
PAF26 in each of the Δcch-1, Δyvc-1, and Δnca-2 mutants were com-
pared with that in the wild type. As a baseline for the comparison, 
four staining patterns were identified in the wild-type macroco-
nidia that could be readily quantified at 30 min intervals following 
treatment with 3.5 µM TMR-PAF26. These staining patterns re-
lated to different events in the time-dependent uptake and distri-
bution to different organelles which precedes eventual cell death, 
initially determined by YO-PRO-1/Propidium Iodide staining. They 
were: (a) Accumulation in multiple small vesicles. These were pre-
dicted to be mostly endosomes typically up to ~1 µm in width. (b) 
Accumulation in 1–3 large vacuole(s) typically greater than ~1.5 µm 
in width. (c) Accumulation in the cytoplasm and excluded from vac-
uoles. This is the stage just after the peptide has been released out 
from vacuoles. (d) Accumulation in both the cytoplasm and vacu-
oles. This is the stage after which the intracellular membranes have 
become permeabilized and thus represents commitment to cell 
death, as previously reported (Muñoz et al., 2012).
In the wild-type macroconidia (Figures 2b and 3a), this quanti-
tative analysis showed that after treatment for 30 min with TMR-
PAF26, all the macroconidia had interacted with TMR-PAF26 and 
many were beginning to internalize the peptide into small vesicles. 
After 60 min, many of the conidia had already undergone vacuolar 
expansion and some had exported the peptide into the cytoplasm, 
and this correlated with a transient reduction in the percentage of 
cells with peptide only localized within small vesicles. After 60 min, 
40% of the cells had actively transported the peptide out of their 
vacuoles and into the surrounding cytoplasm. In another 40% of the 
cells at the 60 min time point, vacuolar membrane permeabilization 
had occurred and the peptide had equilibrated throughout the cells. 
By 120 min, 57% of the cells were permeabilized (Figures 2b and 3a).
2.5 | YVC-1 is required for transport of PAF26 from 
vesicles to vacuoles
When the ∆yvc-1 mutant was treated with the labeled peptide 
(Figures 2b and 3b), it rapidly appeared at the cell envelope. Unlike 
with the wild type, the peptide was internalized into small vesicles 
at a more-or-less linear rate with much remaining trapped at the cell 
surface. Accumulation of the peptide in vacuoles was much slower 
and reached a maximum of 6% of the cells with this localization pat-
tern after 120 min. Virtually no cells were observed with peptide 
exclusively in the cytoplasm at the three time points of measure-
ment over the 120 min by which time only 5% of cells were internally 
permeabilized. After 120 min, 79% of the ∆yvc-1 cells had taken up 
TMR-PAF26 compared with 100% in the wild type. Thus, less TMR-
PAF26 was taken up by ∆yvc-1 cells, most accumulated in small 
vesicles and few cells had internal membrane permeabilization after 
120 min (5% compared with 57% in the wild type). These results are 
consistent with YVC-1 being required for the transport of PAF26 
from vesicles to vacuoles.
2.6 | NCA-2 is required for the interaction of 
PAF26 and the cell envelope
When the ∆nca-2 mutant was treated with TMR-PAF26 (Figures 2b 
and 3c) the cell envelopes of the macroconidia were visibly less fluo-
rescent than that of the wild type. Thus, the affinity of TMR-PAF26 
for the cell envelope of this mutant seemed to be reduced and its 
staining was delayed compared with that of the wild type. The ∆nca-
2 macroconidia also internalized TMR-PAF26 at a far reduced rate 
compared with the other mutants and the peptide mostly became 
trapped within the small vesicles, resulting in virtually no TMR-
PAF26 being taken up by vacuoles and a correspondingly extremely 
small percentage (~2%) of the cells having permeabilized internal 
membranes after 120 min (Figure 2b).
2.7 | CCH-1 plays a key role in the energy- and Ca2+-
dependent internalization of PAF26 by fungal cells
The pattern of TMR-PAF26 internalization and intracellular trans-
port within macroconidia of the Δcch-1 mutant appeared to be 
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F I G U R E  2   Graphical representation showing that the interaction between PAF26 and macroconidia is altered through deletion of 
Ca2+-channels and pumps. (A) shows maximum intensity projections from a Z series captured using confocal microscopy. Initially, the 
peptide appears at the cell envelope and within small vesicles (a). The peptide is then accumulated in larger vesicles and vacuoles (b) until 
there appears a lower number of larger vacuoles (c) which will eventually fuse into a single vacuole which then releases the peptide into 
the cytoplasm (d). Scale bar is 5 µm. (B) shows quantification of this interaction over time for the deletion mutants compared to the wild 
type; there are marked changes in the localization of the peptide during the time course. (C) shows the interaction between PAF26 and 
macroconidia is Ca2+-dependent and energy dependent. This is demonstrated by the significant delay in the uptake of PAF26 in the wild 
type when extracellular free Ca2+ is removed using BAPTA, at top. The peptide remains trapped in small vesicles and there is little transport 
into the vacuolar system and consequently a reduction in internal membrane permeabilization. The lower figure shows the effect of the 
removal of cellular free energy on the Δcch-1 mutant using the metabolic inhibitor NaN3. There is no uptake of PAF26 into the cell and, 
therefore, the direct translocation across the plasma membrane must be an energy-dependent process. N = 100 macroconidia minimum per 
field of view, 10 fields of view per time point, repeated at least twice [Colour figure can be viewed at wileyonlinelibrary.com]
(C)
(A)
(B)
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opposite to that in the wild type (Figure 3d). After treatment for 
30 min the peptide was primarily localized in the cytoplasm (in 67% 
of cells) and to a much lesser extent in small vesicles (~18% of cells) 
and to a very low level in large vacuoles (~5% of cells). Between 30 
and 90 min, TMR-PAF26 was removed from the cytoplasm and in-
creased in amount in the small vesicles and large vacuoles. Between 
90 and 120 min the large vacuoles containing TMR-PAF26 are frag-
menting into smaller vesicles. This was reflected by a dramatic in-
crease in the number of stained small vesicles (Figure 2b).
The overall rate of internalization of TMR-PAF26 by Δcch-1 mac-
roconidia was faster than in the wild type because in the former it 
was initially taken up directly into the cytoplasm while in the latter 
it first appeared intracellularly in small vesicles that are presumed to 
be mostly endosomes. It seems unlikely that TMR-PAF26 is taken 
up by means of non-specific permeabilization of the plasma mem-
brane because this would likely have resulted in rapid cell death. 
Furthermore, 30 min after the addition of TMR-PAF26 it was clear 
that the vacuolar membrane had not become permeabilized because 
the peptide was excluded from the vacuoles of cells in which the 
cytoplasm was fluorescent.
In order to clarify whether the passage of PAF26 across the 
plasma membrane into the cytoplasm of the Δcch-1 mutant was a 
result of passive translocation or active uptake, macroconidia were 
pre-treated with the metabolic inhibitor NaN3 (Muñoz et al., 2012) 
F I G U R E  3   The interaction with 
PAF26 is altered through deletion of 
Ca2+-channels and -pumps as shown by 
visualization of wild-type and mutant 
conidia stained with 3.5 µM TAMRA 
labeled PAF26. These figures show 
maximum intensity projections of Z 
stacks false colored with the “physics” 
lookup table to highlight the different 
fluorescent intensities measured. (A) The 
wild-type conidia undergo a sequence 
of events which ultimately results in 
cell death (Muñoz et al., 2012). (B) The 
Δyvc-1 mutant retains the peptide in small 
vesicles, without the formation of a large 
central vacuole, as in the wild type. (C) 
The Δnca-2 mutant appears much reduced 
in peptide interaction, with very few 
conidia showing the peptide bound to 
the envelope. (D) The process is reversed 
in the Δcch-1 mutant, where the peptide 
first appears within the cytoplasm and 
is pumped into small vesicles which then 
appear to fragment. No conidia were seen 
to completely lose loaded peptide. The 
internalization process is Ca2+ dependent 
and energy-dependent, as chelation of 
Ca2+ with BAPTA (E), and treatment with 
Sodium azide (NaN3) (F), significantly 
reduced uptake of TAMRA-PAF26. 1,000 
individual macroconidia per time point 
per strain. Assay was repeated twice and 
images are representative. Scale bar is 
20 µm [Colour figure can be viewed at 
wileyonlinelibrary.com]
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at a concentration of 5 µM for 15 min before the addition of TMR-
PAF26 and subsequent imaging and quantification of localization 
over 120 min (Figures 2c and 3f).
In the presence of NaN3, over the whole 120 min period of incu-
bation with TMR-PAF26, the peptide remained bound to the cell en-
velope and was not internalized by most of the macroconidia. Clearly 
the metabolic inhibitor NaN3 had almost completely abolished the 
movement of TMR-PAF26 across the plasma membrane indicating 
that the uptake of the peptide into the cells of the Δcch-1 mutant is 
an ATP-dependent process. The results also showed that the rate 
of internal membrane permeabilization, while faster over the first 
30 min, remained similar to that of the non-azide treated Δcch-1 
cells; after 120 min ~ 25% of the cells were fluorescent throughout 
the cell. These results are consistent with the uptake of TMR-PAF26 
by this subpopulation of Δcch-1 macroconidia being energy indepen-
dent as a result of a passive process.
F I G U R E  4   The [Ca2+]cyt response to PAF26 is altered by deletion of Ca
2+ channels and pumps. (A) shows the unstimulated resting level 
of the wild type and the Ca2+ homeostatic mutants: the resting level in Δyvc-1 and Δcch-1 were significantly different from the wild type. 
One-way ANOVA with Dunnet's comparison test: F(3,108) = 32.83, p = ≤.001, R2 = 47.70, R2(adj) = 46.24. (B) shows the [Ca2+]cyt response to 
PAF26 by population wide measurements using the genetically encoded reporter aequorin supplied with an excess of coelenterazine. The 
[PAF26] µM is shown above each measurement series and was added at time 0, baseline measurements were recorded for 50s before the 
addition of the peptide. (C) shows that this response in the wild type is both dependent on external Ca2+ and on the presence of an external 
Ca2+ channel, the biphasic response to 5µM PAF26 (seen in the ddH2O control) is completely abolished following chelation of Ca
2+ with 
BAPTA or treatment with L-Type Ca2+ channel blockers. All measurements are averages of six individual wells in a 96-well plate, with [Ca2+]cyt 
calculated following quenching of the remaining aequorin using EtOH and Ca2+. Error bars are standard deviations. All experiments were 
repeated a minimum of three times and the above figures are representative [Colour figure can be viewed at wileyonlinelibrary.com]
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These results are consistent with the normal endocytic internal-
ization of PAF26 being dependent on the Ca2+ channel protein, CCH-
1. As CCH-1 appears to initiate PAF26 internalization by endocytosis 
(see previous section), this suggests that the uptake of Ca2+ from the 
external medium may be mediated by this Ca2+ channel, which has 
previously been reported to be immunolocalized to the plasma mem-
brane (Locke et al., 2000). Furthermore, we had previously shown 
that removal of Ca2+ from VM made macroconidia more resistant to 
being killed by PAF26. To attempt to mimic the effect of cch-1 dele-
tion in the wild type, Ca2+ was removed from the external medium by 
the addition of the Ca2+ chelator BAPTA (5 mM) 30 min prior to the 
TMR-PAF26 treatment (Figures 2c and 3e). Rather than preventing 
the entry of the peptide, the BAPTA treatment had the unexpected 
effect of trapping the peptide in small vesicles. Over the 120 min 
period very little TMR-PAF26 had localized in large vacuoles, in the 
cytoplasm and only ~11% of the macroconidia had fluorescence 
throughout the cell. The phenotype of the Δcch-1 mutant is consis-
tent with the CCH-1 protein playing a key role in the energy- and 
Ca2+-dependent internalization of PAF26 by fungal cells.
2.8 | The [Ca2+]cyt response during PAF26 treatment 
is disrupted in the [Ca2+]ext tolerant mutants
The wild type had previously been shown to undergo a dose depend-
ent biphasic rise in [Ca2+]cyt upon addition of PAF26 at concentra-
tions between 0.8 and 2.0 µM (Muñoz et al., 2012). The experiment 
was repeated here but with over a concentration range of 1.25-
10 µM PAF26. For all measurements, the unstimulated [Ca2+]cyt rest-
ing level was measured for 50 s, in the wild type this was calculated 
to be 0.05 ± 0.02 µM (Figure 4a), before the peptide was added at 
time 0. After treatment with a low final concentration of PAF26 
(1.25 µM), an immediate increase in [Ca2+]cyt to 0.19 ± 0.01 µM was 
observed and this was sustained throughout the measurement pe-
riod (1,200 s) and slightly increased toward the end of this period 
(Figure 4b). When the PAF26 added was at a final concentration of 
2.5 µM, which is close to its IC50 value, the initial increase in [Ca
2+]cyt 
was slightly greater (to 0.22 ± 0.03 µM) (Figure 4b). Again, this was 
followed by a period of sustained [Ca2+]cyt increase, but there was 
also a more pronounced exponential increase in [Ca2+]cyt which 
began at ~900 s after treatment. With the higher dose, there was 
also an increase in the standard deviations of the measurements 
with time. This is due to aequorin consumption during the course of 
the experiment, resulting in less sensitivity after prolonged exposure 
to high [Ca2+] (note that luminescence measurements from six wells 
are averaged per time point). When the wild type was treated with 
5 µM PAF26, which was above its IC50 value, the [Ca
2+]cyt response 
followed the same general pattern but with a much larger initial 
[Ca2+]cyt increase to 0.32 ± 0.02 µM and a shorter period of sustained 
increase before the [Ca2+]cyt increase became exponential at ~430 s 
(Figure 4b). Furthermore, after 590 s following peptide treatment, 
[Ca2+]cyt spiking was observed. The [Ca
2+]cyt response was further 
accentuated after treatment with a very high dose (10 µM) of PAF26 
resulting in a rapid initial rise in [Ca2+]cyt to 0.54 ± 0.03 µM, followed 
by an immediate exponential increase in [Ca2+]cyt. This in turn was 
followed by the [Ca2+]cyt spiking and then a sudden drop in [Ca
2+]cyt 
after ~220 s, which then exponentially increased and subsequently 
underwent spiking again (Figure 4b).
The unstimulated resting level of [Ca2+]cyt in the ∆yvc-1 mutant 
was measured as 0.02 ± 0.01 µM (Figure 4a), significantly differ-
ent at p > .01. The [Ca2+]cyt response of the ∆yvc-1 strain to PAF26 
was markedly different to that of the wild type. While there was 
a similar initial immediate, dose dependent increase in [Ca2+]cyt, 
there was no second exponential increase in [Ca2+]cyt, which was 
particularly evident after treating the wild type with PAF26 at 
2.5 µM or above (Figure 4b). Instead the ∆yvc-1 mutant underwent 
a slight reduction in [Ca2+]cyt followed by a sustained, more-or-less 
constant [Ca2+]cyt level that was significantly raised compared with 
the unstimulated resting levels recorded prior to treatment. Thus 
the ∆yvc-1 mutant lacked the second [Ca2+]cyt increase of the bi-
phasic [Ca2+]cyt response of the wild type, which is consistent with 
this second [Ca2+]cyt increase resulting from the release of Ca
2+ from 
the vacuole. The resting level of [Ca2+]cyt in the ∆nca-2 mutant was 
measured at 0.05 µM ± 0.02, Figure 4a, and was not significantly 
different from the wild type. In general terms, the ∆nca-2 mutant 
showed a similar response to PAF26 as did the ∆yvc-1 mutant. 
However, the Ca2+ signatures of the ∆nca-2 and ∆yvc-1 mutants 
were clearly but not dramatically different from each other; there 
was a more pronounced dose dependent [Ca2+]cyt increase in the 
∆nca-2 strain compared with that in ∆yvc-1 in response to PAF26 
(Figure 4b). The resting level of [Ca2+]cyt in the ∆cch-1 mutant was 
0.03 ± 0.00 µM Figure 4a, significantly different to the wild type 
at p > .01. Interestingly, deletion of cch-1 does not inhibit the initial 
increase in [Ca2+]cyt after PAF26 addition, surprising given the lack 
of evidence for another Ca2+ channel at the cell surface. The Ca2+ 
signatures of the ∆cch-1 mutant in response to different concen-
trations of PAF26 were broadly similar to those of the ∆yvc-1 and 
∆nca-2 mutants (Figure 4b). Thus the ∆cch-1 mutant also showed 
an initial [Ca2+]cyt increase but lacked the second [Ca
2+]cyt increase 
of the typical biphasic response of the wild type to PAF26. These 
results suggest there may be an unidentified L-type channel within 
the plasma membrane, not CCH-1, being responsible for the initial 
[Ca2+]cyt increase in response to PAF26.
The influence on the [Ca2+]cyt response to 5.0 µM PAF26 of the 
wild type following pre-treatment with 5 mM BAPTA (to chelate ex-
tracellular Ca2+) or with the L-type Ca2+ channel blockers diltiazem 
or verapamil (both at 5 mM), was analyzed (Figure 4c). A 15 min 
pre-treatment with ddH2O (the control) caused a biphasic increase 
in [Ca2+]cyt while all of the other treatments prevented any signifi-
cant [Ca2+]cyt increase (Figure 2). These results are consistent with 
the biphasic [Ca2+]cyt increase being dependent on extracellular Ca
2+ 
as reported before (Muñoz et al., 2012) and on L-type Ca2+ channel 
activity. The only known L-type Ca2+ channel in N. crassa is CCH-
1(Zelter et al., 2004). These results also suggest that the second 
component of the biphasic [Ca2+]cyt increase is dependent on the 
first [Ca2+]cyt increase.
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2.9 | Imaging using the fluorescent reporter 
GCaMP6 shows PAF26 does not cause a dose 
dependent rise in [Ca2+]cyt
In order to investigate whether PAF26 was indeed causing a dose de-
pendent rise in [Ca2+]cyt, conidia expressing GCaMP6s were imaged 
during PAF26 treatment using widefield fluorescence microscopy. 
Individual macroconidia were then isolated from the background in 
FIJI and fluorescence measured over time. As Figure 5a shows, the in-
dividual responses are far more varied than the measurements using 
aequorin suggested. In the middle of the time course, the moment the 
PAF26 reaches the field of view and interacts with the cells can be 
clearly seen in a sudden increase in Ca2+ spiking in all the individuals. 
Given that the aequorin measurements are across a whole popula-
tion, it is not hard to see how the cumulative effects of an increase in 
Ca2+ spikes and waves could be interpreted as a dose dependent rise 
in [Ca2+]cyt.In order to determine whether there was a predictable 
response to PAF26 addition, several repeated experiments were run 
in which the peptide was added and fluorescence intensity recorded. 
No distinct pattern or regularity was found within any of the data 
sets, except for an increase in Ca2+ signaling after PAF26 addition. As 
the only noticeable response, the amplitude and frequency of these 
F I G U R E  5   PAF26 does not cause a dose-dependent rise in [Ca2+]cyt. (A) shows the relative fluorescence intensity of several macroconidia 
expressing GCaMP6s during PAF26 treatment. Fluorescence values are normalized and given as arbitrary values. After the addition of 
PAF26 there is a marked increase in the amplitude and frequency of Ca2+ spiking. (B) Quantification of this revealed an actual increase in 
spiking from an average of four spikes per 30 min to 19 spikes per 30 min (i). The spiking was entirely dependent on the presence of external 
Ca2+ as chelation with BAPTA reduced the frequency of spiking to 0. The amplitude of the individual spikes also increased from 4 to 6 
arbitrary units (ii). (C) these spikes often appeared to correspond to the meeting of vesicles and vacuoles within the cell; the images captured 
between the two arrows are shown in (D) which shows wide field fluorescence images captured every 5 s. The two spikes marked by * in C 
appear to correspond to vacuolar fusion events. Scale bar = 2µm [Colour figure can be viewed at wileyonlinelibrary.com]
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Ca2+ spikes was quantified. Conidia were treated either with ddH2O 
or ddH2O containing 3.5 µM PAF26. A second set were pre-treated 
with 5 mM BAPTA before ddH2O or PAF26 treatment. The conidia 
treated with ddH2O have a relatively low frequency of Ca
2+ spiking 
with the mean being 4 spikes over the course of the measurement. 
This is consistent with our findings as to the rate of Ca2+ spiking in 
germinating and fusing conidia (Read, unpublished). When the cells 
are treated with PAF26 however, there is a marked increase in both 
frequency and amplitude. The mean frequency of the Ca2+ spikes 
increases to 19 and the amplitude increases to around 6 times the 
resting level from 4 (Figure 5b). Both of these results are significant 
at p < .01. When the conidia are pre-treated with BAPTA however, 
all Ca2+ spiking ceases completely. While there were no apparent 
recurring patterns in the spiking events, observations appeared to 
show that they correspond to vesicles and vacuoles coming into 
close proximity. A Ca2+ trace is shown in Figure 5c and images are 
shown in Figure 5d. The images shown in Figure 5d are taken every 
five seconds from the timeframes indicated by the black arrows in 
Figure 5c. The first Ca2+ spike marked by *, appears to correspond 
with the meeting of the two vacuoles at the lower part of the image, 
whether they fuse or not is unclear. In the images corresponding to 
the second spike marked with *, the fusion of two vacuoles is clear 
at the top of the image.
3  | DISCUSSION
3.1 | Ca2+ plays important roles in the mode-of-
action of PAF26
In this research, evidence for Ca2+ signaling and homeostasis having 
a significant role in the PAF26 mode-of-action was obtained initially 
by testing the PAF26 sensitivity of conidia grown in the presence 
or absence of calcium. When the level of calcium in the media is 
kept at a minimal level, tolerance increases. Conversely when the 
level is raised, tolerance decreases. This was confirmed with de-
letion mutants defective in different components of their cellular 
transport machinery of Ca2+. Deletion of most of the Ca2+ channels 
significantly increased the concentrations at which PAF26 inhib-
its fungal growth. The elimination of the high affinity Ca2+ plasma 
membrane channel CCH-1 and the vacuolar channel YVC-1 as well 
as the Ca2+ ATPase resulted in inhibitory concentrations of the pep-
tide approaching the point at which passive membrane permeabili-
zation occurs. Ca2+ has been shown to be an important factor in the 
mechanistics of PMAP-23 against Candida albicans, the disruption 
results in reactive oxygen species (ROS) accumulation which trig-
gers apoptosis (Kim and Lee, 2019). This effect is also seen in the 
peptide CGA-N9 against C. tropicalis (Li et al., 2019). High levels of 
cytosolic free Ca2+ have also been shown to confer protection to 
C. albicans against the antimicrobial MUC7 12mer, thought to be 
by a resulting change in the cell membrane properties preventing 
peptide entry (Lis et al., 2010). It appears in this case that the el-
evated levels of cytosolic free Ca2+ are a stress response designed 
to maximize survival by initiating the endocytosis of PAF26. There 
are significant changes to the pattern of peptide cell interaction 
in the mutants and to the quantity of peptide the mutants take 
up. The mutations in the Ca2+ distribution machinery appear to 
disrupt the internalization and accumulation of the peptide which 
in turn increases tolerance to PAF26. Deletion of nca-2 appears 
to influence the binding of PAF26 to the cell envelope, the Δnca-
2 mutant has been shown to accumulate up to 10 fold more Ca2+ 
than wild-type cells, suggesting that NCA-2 serves to remove Ca2+ 
from the cell (Bowman et al., 2011). We found no significant dif-
ference in the resting level of [Ca2+[cyt from the wild type however 
under unstimulated conditions. Interestingly however, the Δnca-
2 mutant has a membrane potential reversed from the wild type 
due to a lack of cell surface H+ATPase function (Hamam and Lew, 
2012). In S. cerevisiae the H+ATPase is one of the most abundant 
cell surface proteins (Bagnat et al., 2001) and makes up a significant 
amount (up to 10%) of the cell surface in N. crassa (Bowman et al., 
1981). PAF26 has been shown to cause a rapid depolarization of 
the membrane in wild-type cells in an energy-independent manner 
(Muñoz et al., 2012). Given that PAF26 has a net positive charge, 
the membrane potential reversed Δnca-2 should technically not be 
inhibited in PAF26 membrane binding from an electrostatic view. 
It is, therefore, possible to propose that PAF26 directly inhibits 
H+-ATPase action, possibly by direct binding; misfunctioning H+--
ATPase at the plasma membrane is sent to the vacuole for degrada-
tion in yeast, a possible mechanistic for the accumulation of PAF26 
(Bagnat et al., 2001; Liu et al., 2006). When the peptide is internal-
ized in the Δyvc-1 mutant, it remains in small vesicles with very little 
sign of the peptide entering the vacuolar system; adding support 
for the hypothesis that YVC-1 and a threshold amount of PAF26 is 
required to initiate vacuolar fusion. Vacuolar fusion occurs through 
conformational change of the docking SNARE proteins, triggered 
by the release of Ca2+ from the vacuole in S. cerevisiae (Bayer et al., 
2003; Merz and Wickner, 2004; Coonrod et al., 2013). In S. cerevi-
siae, isolated vacuoles are able to catalyze their own fusion through 
the release of Ca2+ from yvc1p present in the vacuolar membrane 
(Peters and Mayer, 1998). This does not appear to be the case in N. 
crassa however, as both deletion of YVC-1 and removal of extracel-
lular Ca2+ resulted in the trapping of the peptide in small vesicles. 
Therefore, extracellular Ca2+ is required to initiate the release of 
Ca2+ from the vacuoles and trigger fusion. This raises questions 
as to why internal membrane fusion is reliant on external stimuli. 
In the Δcch-1 mutant the peptide was directly translocated across 
the plasma membrane into the cytoplasm in an energy dependent 
manner, before accumulation in vacuoles, meaning PAF26 does not 
kill by being present in the cytosolic space. CCH-1 is, therefore, 
required to initiate the endocytic pathway. Energy dependent pep-
tide uptake into the vacuolar system is also seen in the Penicillium 
chrysogenum Penicillium antifungal protein B (PAFB), where the 
fungal cells show no signs of cell death as long as the peptide re-
mains in the vacuole (Huber et al., 2018). This is similarly seen in the 
Neosartorya (Aspergillus) fischeri antifungal protein (NFAP), which is 
also accumulated in the vacuole in an energy dependent maner. 
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Again, this peptide also does not exert its antifungal effects until it 
is present within the cytoplasm (Hajdu et al., 2019). This contrasts 
the findings here of PAF26 being present within the cytoplasmic 
space without killing the cells. The importance of the vacuole in the 
mode of action of many AFPs is becoming increasingly apparent. A 
genetic screen of S. cerevisiae revealed tolerance to the plant anti-
fungal defensins NbD6 and SBI6 could be increased by deletion of 
genes involved in vacuolar transport (Parisi et al., 2019).
Ca2+ measurement at the population level revealed that the Ca2+ 
responses to PAF26 were markedly different in the PAF26 tolerant 
mutants. While all underwent a similar initial increase in [Ca2+]cyt the 
second biphasic increase seen in the wild type was abolished. This 
initial increase was independent of CCH-1, as the signal in the Δcch-
1 mutant increased, but was dependent on external Ca2+ and L-type 
Ca2+ channels. The fact that L-type channel blockers completely stop 
the [Ca2+]cyt increase as does the chelation of external Ca
2+ using 
BAPTA would suggest that there is another, as yet unknown cell sur-
face Ca2+ channel. These findings mirror those of Binder et al. (2010), 
who found that deletion of cch-1 did not prevent the increase in 
[Ca2+] cyt in response to P. chrysogenum Penicillium antifungal protein 
(PAF). When these measurements were taken at the level of the in-
dividual, rather than the population, it became apparent that PAF26 
does not in fact cause a dose dependent rise in [Ca2+]cyt but rather 
increases both the amplitude and frequency of Ca2+ spiking, again 
dependent on the presence of external Ca2+. These findings have 
allowed us to propose the model shown in Figure 6 for the role of 
Ca2+ signaling and homeostasis in the mode of action of PAF26. Now 
the challenge is to identify the trigger of vacuolar release of PAF26 
and the initiator of cell death.
4  | MATERIAL S AND METHODS
4.1 | Neurospora crassa stocks
N. crassa strains were obtained from the Fungal Genetics Stock 
Centre (FGSC, University of Missouri, Kansas City, USA), unless 
otherwise specified. FGSC2489 (matA,74-OR23-1VA) was used as 
the wild-type control. N. crassa strains generated in this study were 
derived from FGSC9717 (matA,∆mus-51::bar+; his-3-), FGSC9720 
(matA,∆mus-52::bar+; his-3-) and FGSC6103 (matA,his-3-) N. crassa 
was cultured and maintained according to FGSC protocols (www.
fgsc.net/Neuro spora /Neuro spora Proto colGu ide.htm) unless other-
wise stated.
For microscopy, conidia were cultured in liquid VM for up to 4 hr 
at 30°C using 8-well Nunc Lab-Tek II Chambered Coverglass.
4.2 | N. crassa transformation
Electroporation of macroconidia was carried out using the following 
settings: resistance 600 Ω, voltage 1.5 kV/cm, and capacitance 25 
μFd.
4.3 | Heterokaryon purification
N. crassa strains that were obtained as heterokaryons, were purified 
to homokaryons by standard procedure (www.fgsc.net/Neuro spora / 
Neuro spora Proto colGu ide.htm).
4.4 | Plasmids
In order to create pTef1AeqS, aequorin was amplified from pAB19 
using the primers AeqS-F and AeqS-R. The vector pCC019 was di-
gested with PacI and EcoRI and the vector gel purified. Aequorin was 
then amplified with AeqS-IF-Fw and AeqS-IF-Rv to add overlaps ho-
mologous to the backbone while maintaining the digestion sites and 
the vector was assembled using Gibson assembly. Primer sequences 
are given in supplementary material.
4.5 | IC50 values
IC50 values were calculated using clear, U bottom polystyrene microti-
tre plates. PAF 26 was prepared at two concentrations, 35 and 30 µM, 
and diluted two-fold appropriately in to reach the final experimental 
F I G U R E  6   Proposed role of Ca2+ signaling in the mode of 
action of PAF26. (1) initially the cell is unstimulated and maintains 
a low [Ca2+]cyt and stable membrane potential. (2) PAF26 inhibits 
the cell surface H+ATPase initiating membrane depolarization. (3) 
Depolarization of the plasma membrane activates the voltage gated 
CCH-1, causing [Ca2+]cyt to rise. (4) This rise in [Ca
2+]cyt initiates the 
turnover of the H+ATPase including bound PAF26 by endocytosis. 
(5) further rises in [Ca2+]cyt caused by external Ca
2+ entering 
through CCH-1 initiate Ca2+ release through YVC-1 (6) driving the 
fusion of membranes. (7) PAF26 is released from the H+ATPase as it 
is degraded and accumulates in the vacuolar system [Colour figure 
can be viewed at wileyonlinelibrary.com]
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concentrations. Conidia were diluted to a concentration of 1 X 106 in 
20% liquid VM and 50 µl dispensed into each well. Experimental PAF26 
concentrations (µM) were: [17.50][15.00][8.75][7.50][4.38][3.75][2.19]
[1.88][1.09][0.94][0.55][0]. Final conidial concentration was of 5 × 105 
in 10% VM. Absorbance measurements were obtained at 610 nm. This 
wavelength is close to the 595nm at which the relationship between 
optical density and fungal biomass is linear (Broekaert et al., 1990).
4.6 | Calcium measurements
Coelenterazine (#C-7001, www.biosy nth.com) was prepared by dis-
solving in ice cold methanol (MetOH) under a protective atmosphere 
in complete darkness to a concentration of 10 µg/µl. Stocks were 
diluted to the working concentration of 3.175 µg in 10 µl MetOH, 
74.78 µM.
Conidia were diluted to a concentration of 1 × 106 in 10% VM, 
coelenterazine was added to a final concentration of 2.5 µM. 100 µl of 
conidial suspension was used per well of a white microtitre plate and 
the plates incubated at 25°C in the dark for 6 hr. The light output of 
aequorin was measured by counting the photons emitted by a single 
well over 1 s, each well in a row of six being measured once every cycle 
of 7 s. After recording baseline luminescence, a single row was treated 
with PAF26 and the light output measured over time. Following this 
the second row was run with 100 µl 3M CaCl2:20% ethanol (EtOH) 
injected on cycle 8 to immediately discharge all the aequorin.
4.7 | [Ca2+] calculation
The raw relative light units (RLU) were converted to [Ca2+] using the 
formula: (Bonora et al., 2013)
where, L, is the light intensity at sampling time; Lmax, is the total 
light emitted at sampling time; KR, is the constant for calcium bound 
state (7,230,000); KTR, is the constant for calcium unbound state 
(120); λ, is the rate constant for aequorin consumption at saturating 
[Ca2+] (1); n, is the number of Ca2+ binding sites (2.99).
In order to calculate Lmax the total RLU (RLUtotal) available was 
calculated from the discharge of aequorin (RLUd) using the trape-
zoid rule formula, where the total RLUd available at time point tn 
equals:
and RLUdtotal is the final value reached. Switching to the experi-
mental data (RLUe), Lmax was calculated for each time point as:
4.8 | Peptides and peptide handling
Peptides were ordered from GenScript (www.gensc ript.com) 
at >98% purity. Stock solutions were prepared in 50:50 dimethyl 
sulfoxide (DMSO):H2O buffer. Working peptide solutions were pre-
pared in ddH2O.
4.9 | Microscopy
All microscopy was carried out on a Nikon Eclipse TE2000-E inverted 
microscope, using a Nikon Plan Apo 60 X 1.2 N.A. DIC H water im-
mersion objective and Nikon G-2A and B-2A filter sets, excitation 
was provided by a CoolLED illumination system set at 550 nm for use 
with the G-2A filter or 470 nm for use with the B2-A filter.
Confocal microscopy was carried out using a Leica TCS SP8 
equipped with two hybrid GaAsP detectors (HyD) and two pho-
tomultiplier tubes (PMT). Excitation was provided using either the 
Leica tuneable white light laser (450–750 nm), an argon laser (458, 
476, 488 and 496 nm) or UV laser (405 nm). Images were captured 
using LAS X software and the Leica 63 X water immersion ob-
jective. All image handling and analysis was carried out using Fiji 
(fiji.sc/Fiji).
4.10 | Quantification of Ca2+ signaling
Fluorescence values were exported from Fiji and analyzed in Excel. 
Data were normalized using feature scaling. This scales the data 
to remove irregularities in GCaMP6 expression and photon yield. 
The function used was: xI = MIN + (x-minx)(MAX-MIN)/(maxx-minx). 
Where MIN and MAX are the required scale range, x is the original 
value and xI is the normalized value. minx is the minimum value for 
that data set and maxx is the maximum, maxx was defined as the 
maximum value from all experiments plus 10 to avoid artificial am-
plification of noise. The noise was removed using an IF function: 
=IF(x > y, x, 0) where x is the data point and y is the noise thresh-
old limit. Finally, an IF(AND(x > x–1, x > x+1),1,0) function, where x–1 
and x+1 are the surrounding measurements, quantified each peak in 
GCamP6 fluorescence.
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